Avantor, Inc.
Avantor, Inc. (AVTR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVTR · as of Jun 8, 2026
Key Statistics
Explore Avantor, Inc. Data
avtr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 34.6%
The AVTR analyst consensus is Hold, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $9.17, representing +0.11% upside from the current price of $9.16.
Competitors & Peers
avtr competitorsAVTR
ATR
BAX
BIO
GRFS
HSICStock Performance
Full HistoryAbout Avantor, Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the…
what is avantor, inc. · avtr stock overview · avantor, inc. company profile · who is avantor, inc. ceo · avtr NYSE · avantor, inc. headquarters · avantor, inc. business segments
About Stock Overview & Key Data
Avantor, Inc. (AVTR) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since May 17, 2019. As of the latest trading session, AVTR stock price is $9.16, with a market capitalization of $6.3B. The stock has returned -31.90% over the past 12 months and -20.07% year-to-date.
According to 26 Wall Street analysts, the consensus rating for Avantor, Inc. stock is Hold, with an average 12-month price target of $9.17. In fiscal year 2025, Avantor, Inc. reported revenue of $6.6B and net income of -$530.2M. For detailed data — including Avantor, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Avantor, Inc. (AVTR) stock price is $9.16. The stock is traded on NYSE under the ticker symbol AVTR. The 52-week range is $7.26 – $15.93.